HSBC Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,111
| Closed | -$36.8K | – | 2783 |
|
|
2024
Q4 | $36.8K | Sell |
12,111
-1,158,327
| -99% | -$3.52M | ﹤0.01% | 2577 |
|
|
2024
Q3 | $6.21M | Buy |
1,170,438
+1,155,481
| +7,725% | +$6.13M | ﹤0.01% | 871 |
|
|
2024
Q2 | $38.5K | Buy |
+14,957
| New | +$38.5K | ﹤0.01% | 2464 |
|
|
2023
Q1 | – | Sell |
-19,000
| Closed | -$350K | – | 2549 |
|
|
2022
Q4 | $350K | Buy |
+19,000
| New | +$350K | ﹤0.01% | 2004 |
|
|
2022
Q3 | – | Sell |
-88,773
| Closed | -$1.23M | – | 2817 |
|
|
2022
Q2 | $1.23M | Buy |
88,773
+28,665
| +48% | +$397K | ﹤0.01% | 1498 |
|
|
2022
Q1 | $1.17M | Buy |
60,108
+2,078
| +4% | +$40.6K | ﹤0.01% | 1551 |
|
|
2021
Q4 | $947K | Sell |
58,030
-7,751
| -12% | -$126K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $1.84M | Buy |
65,781
+55,603
| +546% | +$1.55M | ﹤0.01% | 1237 |
|
|
2021
Q2 | $301K | Buy |
+10,178
| New | +$301K | ﹤0.01% | 2094 |
|